0FU837Z
Supplement Cystic Duct to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | U Supplement |
| Body Part | 8 Cystic Duct |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment hepatobiliary or pancreatic tissue that's still in place, rather than replacing or repairing it outright. Examples include applying mesh or a biologic patch to reinforce a fragile area of liver capsule after a partial excision, or buttressing a pancreatic anastomosis with additional material to reduce the risk of a postoperative leak.
Surgeons turn to these techniques when native tissue is structurally weak, at risk of failure, or benefits from added support to hold a repair together, particularly around suture lines and areas prone to leakage of bile or pancreatic fluid. This differs from simply repairing a defect because material beyond the patient's own tissue is deliberately introduced to strengthen the area going forward.
Anatomy & Axis Detail
Cystic Duct
The cystic duct is the short, tortuous channel bearing the spiral valves of Heister that connects the gallbladder neck to the common bile duct, and it is rarely the direct target of supplementation except when its wall has been weakened by chronic inflammation, prior instrumentation, or is reconstructed as part of a biliary reconstruction. Supplementing the cystic duct typically involves reinforcing a repaired or thinned segment with an autologous graft, such as adjacent peritoneum, or a synthetic patch to restore structural integrity without replacing the duct's own tissue. Because the duct's small caliber and proximity to the triangle of Calot make dissection hazardous, documentation should specify the graft material and confirm that native ductal tissue was augmented rather than excised, distinguishing this from a Replacement procedure.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should look for explicit mention of a graft, mesh, or biologic patch placed to reinforce or bolster existing tissue, since Supplement requires that the underlying body part remains and is only being strengthened. The material used and its placement site should be documented clearly enough to assign the correct device character. A recurring error is coding Supplement when the material actually substituted for excised tissue rather than reinforcing tissue left behind, which belongs under Replacement instead, so coders need to confirm whether any of the original structure was removed.